How to Use Stock Screeners: What They Can and Can't Tell You
Quick answer: Stock screeners filter large universes of stocks down to smaller lists based on quantitative criteria — P/E ratio, revenue growth, dividend yield, market cap, and dozens of other metrics. They're useful for generating ideas and narrowing a search. They cannot evaluate business quality, competitive positioning, earnings quality, management integrity, or whether a stock is genuinely undervalued. A screener finds candidates; research determines whether any of them are worth owning.
What screeners are good for
Generating ideas efficiently. Instead of reading about 5,000 stocks to find candidates, a screener lets you filter down to 20–50 that meet your initial criteria in seconds.
Enforcing discipline. If you only want stocks with a P/E below 15, debt-to-equity below 0.5, and 10+ years of dividend growth, a screener enforces those criteria consistently — you won't talk yourself into exceptions the way you might browsing manually.
Quantitative starting points. Identifying companies with improving margins, accelerating revenue growth, or rising returns on capital is a reasonable starting point for further research.
What screeners cannot tell you
Whether the business is actually good. A low P/E might mean a stock is cheap, or it might mean the business is in structural decline. A screener can't tell the difference.
Whether the earnings are real. A screener uses reported numbers. If those numbers are inflated by aggressive accounting, the screener ranks the stock favorably for the wrong reasons.
Whether management is trustworthy. No financial metric captures whether the people running the company make good decisions and communicate honestly.
Whether competitive advantages are durable. A company can have excellent historical metrics and a deteriorating competitive position that doesn't show up in the numbers yet.
Professor Aswath Damodaran of NYU Stern Business School cautions that screening for cheap stocks by metrics is the beginning of analysis, not the end. Many stocks that look cheap by one metric are cheap for good reason — the market has already priced in the deterioration that the backward-looking screener hasn't captured yet. — The Little Book of Valuation, Wiley
Common screening approaches and their limitations
Value screens (low P/E, low price-to-book)
Produce lists of statistically cheap stocks. Many will be value traps — genuinely cheap because the business is deteriorating. Research is required to distinguish cheap-and-bad from cheap-and-overlooked.
Growth screens (high revenue growth, expanding margins)
Produce lists of fast-growing companies. Many will be priced for perfection with no margin for error. Research is required to determine whether growth is durable and the price is reasonable.
Quality screens (high return on equity, low debt, consistent earnings)
Produce lists of financially strong companies. Many will be appropriately priced or expensive. Research is required to find the ones offering reasonable value.
A practical screener workflow
- Set broad criteria aligned with your investment approach — not so narrow you miss good candidates, not so broad the list is unmanageable.
- Generate a list of 20–50 candidates.
- Do a quick 15-minute pass on each: what does the company do, does the business model make sense, any obvious red flags?
- Narrow to 5–10 worth deeper research.
- Do full research on the finalists — business quality, competitive position, valuation, earnings quality, management, risks.
Peter Lynch screened with his feet — he researched companies he encountered as a consumer, a professional, or through industry contacts. The best investment ideas often come from understanding a business firsthand, then confirming the financials, rather than from a quantitative screen that tells you nothing about the business itself.
AlphaLens does this analysis in seconds
15 structured research frameworks. Any US stock. Live SEC filings, real-time news, powered by Advanced AI.
Try AlphaLens Free → Use code REDDIT-FREE-TRIAL · No card required · Then $39/mo or $299/yrHow AlphaLens fits into a screening workflow
A stock screener gets you to a short list. AlphaLens takes over from there — running the full 15-framework research process on each candidate to evaluate what a screener can't: business quality, competitive moat, earnings integrity, management track record, and genuine margin of safety. The screening phase takes minutes; the AlphaLens analysis takes seconds.
Where to go deeper
For a detailed walkthrough of each research framework, see the complete guide to all 15 AlphaLens frameworks.
For definitions of investing terms, see the AlphaLens investing glossary.